Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, germany

Experimental and Clinical Endocrinology and Diabetes

Volumn 118, Issue 4, 2010, Pages 245-249

  Kordonouri, O ^a   Hartmann, R ^a   Charpentier, N ^a   Knip, M ^b   Danne, T ^a   Ilonen, J ^c,d  

^a Children's Hospital Auf der Bult   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Age differences; Autoantibodies; Children; Diabetes; GADA; HLA; IA 2A; IAA; PTPN22 polymorphisms

Indexed keywords

AUTOANTIBODY; DIABETES ASSOCIATED AUTOANTIBODY GLUTAMIC ACID DECARBOXYLASE; DIABETES ASSOCIATED AUTOANTIBODY IA 2A; DIABETES ASSOCIATED AUTOANTIBODY PROTEIN TYROSINE PHOSPHATASE 1A 2A; GLUTAMATE DECARBOXYLASE; INSULIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE 1A 2A; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC RISK; GENOTYPE; GERMANY; HAPLOTYPE; HLA SYSTEM; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; AGE OF ONSET; ALLELES; AUTOANTIBODIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HAPLOTYPES; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; POLYMORPHISM, GENETIC; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 22; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 77951052048     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0029-1246213     Document Type: Article

References (24)

1. Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ 2006 175 165-170
2. Devendra D, Eisenbarth GS. Immunologic endocrine disorders. J Allergy Clin Immunol 2003 111 624-636
3. Bell GI, Horita S, Karam JH. A polymorphic locus near the insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984 33 176-183
4. Ueda H, Howson JM, Esposito L, etal. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 2003 423 506-511
5. Bottini N, Musumeci L, Alonso A, etal. A functional variant of lymphoid tyrosine phosphatase is associated with type 1 diabetes. Nature Genetics 2004 36 337-338
6. Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974 30 1279-1283
7. Leslie RD, Atkinson MA, Notkins AL. Autoantigens IA-2A and GADA in type 1 (insulin-dependent) diabetes. Diabetologia 1999 42 3-14
8. Knip M, Vähäsalo P, Karjalainen J, etal. Natural history of preclinical IDDM in high-risk siblings. The Childhood Diabetes in Finland Study Group. Diabetologia 1994 7 388-393
9. Bingley PJ, Bonifacio E, Williams AJ, etal. Predicition of IDDM in the general popluation: strategies based on combinations of autoantibody marker. Diabetes 1997 46 1701-1710
10. Hermann R, Turpeinen H, Laine AP, etal. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: An analysis of 622 nuclear families. Tissue Antigens 2003 62 162-169
11. Hermann R, Lipponen K, Kiviniemi M, etal. Lymphoid tyrosine phosphatase (LYP/PTPN22) Arg620Trp variant regulates insulin autoimmunity and progression to type 1 diabetes. Diabetologia 2006 49 1198-1208
12. Sabbah E, Savola K, Ebeling T, etal. Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes. Diabetes Care 2000 23 1326-1332
13. Kahles H, Ramos-Lopez E, Lange B, etal. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur J Endocrinol 2005 153 895-899
14. Santiago JL, Martinez A, de la Calle H, etal. Susceptibility to type 1 diabetes conferred by the PTPN22 C1858T polymorphism in the Spanish population. BMC Medical Genetics 2007 8 54-58
15. Van der Auwera, Vandewalle CL, Schuit FC, etal. CTLA-4 gene polymorphism confers susceptibility to insulin-dependent diabetes mellitus (IDDM) independently from age and from other genetic or immune disease markers. Clin Exp Immunol 1997 110 98-103
16. Cauchi S, Meyre D, Durand E, etal. Post genome-wide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS ONE 2008 3 e2031
17. Ferrari U, Gohlke H, Bonifacio E, etal. SLC30A8-Polymorphismen sind assoziiert mit frhem Diabetesbeginn von Typ 1. Diabetologie & Stoffwechsel 2008 3 S25-S26
18. EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet 2000 356 1690
19. Sabbah E, Savola K, Kulmala P, etal. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. J Clin Endocrinol Metab 1999 84 1534-1539
20. Graham J, Hagopian WA, Kockun I, etal. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002 51 1346-1355
21. Decochez K, Truyen I, van der Auwera B, etal. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. Diabetologia 2005 48 687-694
22. Lempainen J, Vaarala O, Mäkelä M, etal. Interplay between PTPN22 C1858T polymorphism and cow's milk formula exposure in type 1 diabetes. J Autoimmun 2009 33 155-164
23. Achenbach P, Ziegler AG. Diabetes-related antibodies in euglycemic subjects. Best Pract Res Clin Endocrinol Metab 2005 19 101-117
24. Ludvigsson J, Faresj M, Hjorth M, etal. GAD treatment and insulin secretion in recent-onset type 1 diabetes. N Engl J Med 2008 359 1909-1920